Citations (316)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Shiqi Zhou, Yuan Luo & Jonathan F. Lovell. (2023) Vaccine approaches for antigen capture by liposomes. Expert Review of Vaccines 22:1, pages 1022-1040.
Read now
Read now
Yarong Zeng, Feihong Zou, Ningshao Xia & Shaowei Li. (2023) In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives. Expert Review of Vaccines 22:1, pages 681-695.
Read now
Read now
Wenhui Xue, Tingting Li, Ying Gu, Shaowei Li & Ningshao Xia. (2023) Molecular engineering tools for the development of vaccines against infectious diseases: current status and future directions. Expert Review of Vaccines 22:1, pages 563-578.
Read now
Read now
Eddie Underwood, Lisa M. Dunkle, Shabir A. Madhi, Cynthia L. Gay, Paul T. Heath, Karen L. Kotloff, Katherine Smith, Gordon Chau, Shirley Galbiati, Alice McGarry, Wayne Woo, Iksung Cho, Katia Alves, Germán Áñez, Chijioke Bennett, Vivek Shinde, Louis Fries, Raburn M. Mallory, Gregory M. Glenn & Seth Toback. (2023) Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine. Expert Review of Vaccines 22:1, pages 501-517.
Read now
Read now
Béatrice Laupèze & T. Mark Doherty. (2023) Maintaining a ‘fit’ immune system: the role of vaccines. Expert Review of Vaccines 22:1, pages 256-266.
Read now
Read now
Laura Gobbi, Francesca Katiana Martino, Elena Sgrò, Federico Nalesso & Lorenzo A. Calo’. (2023) Varicella Zoster vaccination in hemodialysis patients: The state of the art. Human Vaccines & Immunotherapeutics 19:3.
Read now
Read now
Michael Quagliata, Anna Maria Papini & Paolo Rovero. (2023) Malaria vaccines. Expert Opinion on Therapeutic Patents 33:3, pages 169-178.
Read now
Read now
Linda Stertman, Anna-Karin E. Palm, Behdad Zarnegar, Berit Carow, Carolina Lunderius Andersson, Sofia E. Magnusson, Cecilia Carnrot, Vivek Shinde, Gale Smith, Gregory Glenn, Louis Fries & Karin Lövgren Bengtsson. (2023) The Matrix-M™ adjuvant: A critical component of vaccines for the 21st century. Human Vaccines & Immunotherapeutics 19:1.
Read now
Read now
Ilaria Galgani, Airi Põder, Rain Jõgi, Veli-Jukka Anttila, Stefano Milleri, Alberto M. Borobia, Odile Launay, Marco Testa, Daniela Casula, Luca Grassano, Annaelisa Tasciotti, Marie Dozot & Ashwani K. Arora. (2023) Immunogenicity and safety of the non-typable Haemophilus influenzae–Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial. Human Vaccines & Immunotherapeutics 19:1.
Read now
Read now
Marta Ulaszewska, Sarah Merelie, Sarah Sebastian & Teresa Lambe. (2023) Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster. Human Vaccines & Immunotherapeutics 19:1.
Read now
Read now
Yang Lu & Ge Liu. (2022) Nano alum: A new solution to the new challenge. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Alemnew F. Dagnew, Peter Vink, Mamadou Drame, David O. Willer, Bruno Salaun & Anne E. Schuind. (2021) Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview. Human Vaccines & Immunotherapeutics 17:11, pages 4132-4143.
Read now
Read now
G. G. Guerrero Manriquez & I. Tuero. (2021) Adjuvants: friends in vaccine formulations against infectious diseases. Human Vaccines & Immunotherapeutics 17:10, pages 3539-3550.
Read now
Read now
José Adão Carvalho Nascimento Júnior, Anamaria Mendonça Santos, Rafael Ciro Marques Cavalcante, Lucindo José Quintans-Júnior, Cristiani Isabel Banderó Walker, Lysandro Pinto Borges, Luiza Abrahão Frank & Mairim Russo Serafini. (2021) Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines. Drug Development and Industrial Pharmacy 47:4, pages 673-684.
Read now
Read now
Deepyan Chatterjee & Ian Andrew Cockburn. (2021) The challenges of a circumsporozoite protein-based malaria vaccine. Expert Review of Vaccines 20:2, pages 113-125.
Read now
Read now
Rinku Sharma, Arivukarasu Palanisamy, Kuldeep Dhama, Gorakh Mal, Birbal Singh & Karam Pal Singh. (2020) Exploring the possible use of saponin adjuvants in COVID-19 vaccine. Human Vaccines & Immunotherapeutics 16:12, pages 2944-2953.
Read now
Read now
Yolanda Guerra Mendoza, Elodie Garric, Amanda Leach, Marc Lievens, Opokua Ofori-Anyinam, Jean-Yves Pirçon, Jens-Ulrich Stegmann, Pascale Vandoolaeghe, Lucas Otieno, Walter Otieno, Seth Owusu-Agyei, Jahit Sacarlal, Nahya Salim Masoud, Hermann Sorgho, Marcel Tanner, Halidou Tinto, Innocent Valea, Ali Takadir Mtoro, Patricia Njuguna, Martina Oneko, Godfrey Allan Otieno, Kephas Otieno, Samwel Gesase, Mary J Hamel, Irving Hoffman, Seyram Kaali, Portia Kamthunzi, Peter Kremsner, Miguel Lanaspa, Bertrand Lell, John Lusingu, Anangisye Malabeja, Pedro Aide, Pauline Akoo, Daniel Ansong, Kwaku Poku Asante, James A Berkley, Samuel Adjei, Tsiri Agbenyega, Selidji Todagbe Agnandji & Lode Schuerman. (2019) Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa. Human Vaccines & Immunotherapeutics 15:10, pages 2386-2398.
Read now
Read now
Nicolas Lecrenier, Pierre Beukelaers, Romulo Colindres, Desmond Curran, Carine De Kesel, Jean-Philippe De Saegher, Arnaud M Didierlaurent, Edouard Y Ledent, Johann F Mols, Tomas Mrkvan, Marie Normand-Bayle, Lidia Oostvogels, Fernanda Tavares Da Silva, Ventzislav Vassilev, Carlota Vinals & Alain Brecx. (2018) Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention. Expert Review of Vaccines 17:7, pages 619-634.
Read now
Read now
Eduardo de Gomensoro, Giuseppe Del Giudice & T. Mark Doherty. (2018) Challenges in adult vaccination. Annals of Medicine 50:3, pages 181-192.
Read now
Read now
Anthony L. Cunningham & Thomas Heineman. (2017) Vaccine profile of herpes zoster (HZ/su) subunit vaccine. Expert Review of Vaccines 16:7, pages 661-670.
Read now
Read now
Nidhi Chauhan, Sukirti Tiwari, Tessy Iype & Utkarsh Jain. (2017) An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators. Expert Review of Vaccines 16:5, pages 491-502.
Read now
Read now
Articles from other publishers (295)
Fei Sun, Yingbo Wu, Yuanxing Zhang, Qin Liu, Qiyao Wang & Xiaohong Liu. (2024) An aluminium adjuvant compound with ginseng stem leaf saponins enhances the potency of inactivated Pseudomonas plecoglossicida vaccine in large yellow croaker (Larimichthys crocea). Fish & Shellfish Immunology 144, pages 109243.
Crossref
Crossref
Adrián Plata & Alberto Fernández‐Tejada. 2023. Carbohydrate‐Based Therapeutics. Carbohydrate‐Based Therapeutics
73
110
.
Anthony L. Cunningham, Kerrie J. Sandgren & Naomi R. Truong. (2023) Advances in understanding the mechanism of action of adult vaccines. Journal of Clinical Investigation 133:23.
Crossref
Crossref
Hui Liu, Yao Zhang, Feng Liu, Lisha Ye, Xin Liu, Chunqun Wang & Min Hu. (2023) Progress and challenges for developing vaccines against gastrointestinal nematodes of ruminants. Veterinary Vaccine 2:3-4, pages 100041.
Crossref
Crossref
Carson L. Smith, Brian Richardson, Michael Rubsamen, Mark J. Cameron, Cheryl M. Cameron & David H. Canaday. (2023) Adjuvant AS01 activates human monocytes for costimulation and systemic inflammation. Vaccine.
Crossref
Crossref
Nadia Ouaked, Marie-Ange Demoitié, Fabrice Godfroid, Marie-Cécile Mortier, Yannick Vanloubbeeck & Stéphane T. Temmerman. (2023) Non-clinical evaluation of local and systemic immunity induced by different vaccination strategies of the candidate tuberculosis vaccine M72/AS01. Tuberculosis 143, pages 102425.
Crossref
Crossref
Han Gyu Choi, Kee Woong Kwon & Sung Jae Shin. (2023) Importance of adjuvant selection in tuberculosis vaccine development: Exploring basic mechanisms and clinical implications. Vaccine: X 15, pages 100400.
Crossref
Crossref
Selin Parmaksız, Mert Pekcan, Aykut Özkul, Ece Türkmen, Vanessa Rivero-Arredondo, Luis Ontiveros-Padilla, Neil Forbes, Yvonne Perrie, Constantino López-Macías & Sevda Şenel. (2023) In vivo evaluation of new adjuvant systems based on combination of Salmonella Typhi porins with particulate systems: Liposomes versus polymeric particles. International Journal of Pharmaceutics 648, pages 123568.
Crossref
Crossref
Stefan H. E. Kaufmann. (2023) Vaccine development against tuberculosis before and after Covid-19. Frontiers in Immunology 14.
Crossref
Crossref
Sivakumar S. Moni, Siddig Ibrahim Abdelwahab, Aamena Jabeen, Mohamed Eltaib Elmobark, Duaa Aqaili, Gassem Ghoal, Bassem Oraibi, Abdulla Mohammed Farasani, Ahmed Ali Jerah, Mahdi Mohammed A. Alnajai & Abdul Majeed Hamad Mohammad Alowayni. (2023) Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations. Vaccines 11:11, pages 1704.
Crossref
Crossref
Lawrence Petherbridge, Charlotte Davis, Angela Robinson, Thomas Evans & Sarah Sebastian. (2023) Pre-Clinical Development of an Adenovirus Vector Based RSV and Shingles Vaccine Candidate. Vaccines 11:11, pages 1679.
Crossref
Crossref
Tetsuo Nakayama, Takashi Ito, Ryoka Ishiyama & Kazuhiko Katayama. (2023) Cytokine and Chemokine Production in Mice Inoculated with NVX-CoV2373 (Nuvaxovid®) in Comparison with Omicron BA.4/5 Bivalent BNT162b2 (Comirnaty®). Vaccines 11:11, pages 1677.
Crossref
Crossref
Xinhong Li, Yiting Chen, Rui Wang, Enhao Lu, Kuankuan Luo & Xianyi Sha. (2023) Enhancement of cancer immunotherapy using CRT valgus tumor cell membranes coated bacterial whole peptidoglycan combined with radiotherapy. International Journal of Pharmaceutics 646, pages 123430.
Crossref
Crossref
Simon Doss-Gollin, Sanya Thomas, Byron Brook, Kimia Abedi, Célia Lebas, Floriane Auderset, Yamile Lugo-Rodriguez, Guzman Sanchez-Schmitz, David J. Dowling, Ofer Levy & Simon D. van Haren. (2023) Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen. npj Vaccines 8:1.
Crossref
Crossref
Alisa Hamilton, Fardad Haghpanah, Mateusz Hasso-Agopsowicz, Isabel Frost, Gary Lin, Emily Schueller, Eili Klein & Ramanan Laxminarayan. (2023) Modeling of malaria vaccine effectiveness on disease burden and drug resistance in 42 African countries. Communications Medicine 3:1.
Crossref
Crossref
Badiaa Bouzya, Ronan Nicolas Rouxel, Lionel Sacconnay, Romuald Mascolo, Laurence Nols, Stéphanie Quique, Loïc François, Anne Atas, Lucile Warter, Nancy Dezutter & Clarisse Lorin. (2023) Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models. npj Vaccines 8:1.
Crossref
Crossref
Zhen Li, Isra Rana, Gyungdeuk Park, Jinwoo Lee, Chae Eun Park & Jutaek Nam. (2023) Pattern recognition receptors and their nano-adjuvants for cancer immunotherapy. Journal of Pharmaceutical Investigation.
Crossref
Crossref
Eric A. Toth, Alexander K. Andrianov & Thomas R. Fuerst. (2023) Prospects for developing an Hepatitis C virus E1E2‐based nanoparticle vaccine. Reviews in Medical Virology 33:5.
Crossref
Crossref
Lionel Sacconnay, Jonathan De Smedt, Vera Rocha-Perugini, Edison OngRomuald MascoloAnne Atas, Carline Vanden Abeele, Magali de Heusch, Nathalie De Schrevel, Marie-Pierre David, Badiaa Bouzya, Kim Stobbelaar, Yannick VanloubbeeckPeter L. Delputte, Corey P. Mallett, Nancy Dezutter & Lucile Warter. (2023) The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains. Science Translational Medicine 15:710.
Crossref
Crossref
Ying Zhang, Jin-chuan Xu, Zhi-dong Hu & Xiao-yong Fan. (2023) Advances in protein subunit vaccines against tuberculosis. Frontiers in Immunology 14.
Crossref
Crossref
Deepak B. Salunke & Craig W. Lindsley. (2023) Call for Papers: Medicinal Chemistry of Next Generation Vaccine Adjuvants. ACS Medicinal Chemistry Letters 14:8, pages 1009-1011.
Crossref
Crossref
Deepak B. Salunke & Craig W. Lindsley. (2023) Call for Papers: Medicinal Chemistry of Next Generation Vaccine Adjuvants. Journal of Medicinal Chemistry 66:15, pages 10119-10121.
Crossref
Crossref
Mengyu Guo, Muya Xiong, Jinying Peng, Tong Guan, Haixia Su, Yanyi Huang, Cai-Guang Yang, Yang Li, Diana Boraschi, Thanigaimalai Pillaiyar, Guanbo Wang, Chengqi Yi, Yechun Xu & Chunying Chen. (2023) Multi-omics for COVID-19: driving development of therapeutics and vaccines. National Science Review 10:9.
Crossref
Crossref
Dhruv N. Desai, Ahmed Mahal, Rajat Varshney, Ahmad J. Obaidullah, Bhawna Gupta, Pratikhya Mohanty, Priyabrata Pattnaik, Nrusingha Charan Mohapatra, Snehasish Mishra, Venkataramana Kandi, Ali A. Rabaan & Ranjan K. Mohapatra. (2023) Nanoadjuvants: Promising Bioinspired and Biomimetic Approaches in Vaccine Innovation. ACS Omega 8:31, pages 27953-27968.
Crossref
Crossref
Isabela Resende Azevedo, Thais Akemi Amamura & Lourdes Isaac. (2023) Human leptospirosis: In search for a better vaccine. Scandinavian Journal of Immunology.
Crossref
Crossref
Hongze Ren, Wencong Jia, Yujie Xie, Meihua Yu & Yu Chen. (2023) Adjuvant physiochemistry and advanced nanotechnology for vaccine development. Chemical Society Reviews 52:15, pages 5172-5254.
Crossref
Crossref
Francesco Tognetti, Massimiliano Biagini, Maxime Denis, Francesco Berti, Domenico Maione & Daniela Stranges. (2023) Evolution of Vaccines Formulation to Tackle the Challenge of Anti-Microbial Resistant Pathogens. International Journal of Molecular Sciences 24:15, pages 12054.
Crossref
Crossref
Tingmei Zhao, Yulong Cai, Yujie Jiang, Xuemei He, Yuquan Wei, Yifan Yu & Xiaohe Tian. (2023) Vaccine adjuvants: mechanisms and platforms. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Kelly M. Rausch, Emma K. Barnafo, Lynn E. Lambert, Olga Muratova, J. Patrick Gorres, Charles Anderson, David L. Narum, Yimin Wu, Robert D. Morrison, Irfan Zaidi & Patrick E. Duffy. (2023) Preclinical evaluations of Pfs25-EPA and Pfs230D1-EPA in AS01 for a vaccine to reduce malaria transmission. iScience 26:7, pages 107192.
Crossref
Crossref
Erwin G. Abucayon, Rodell C. Barrientos, Oscar B. Torres, Scott Sweeney, Connor Whalen & Gary R. Matyas. (2023) A Liquid Chromatography High-Resolution Tandem Mass Spectrometry Method to Quantify QS-21 Adjuvant and Its Degradation Products in Liposomal Drug Formulations. ACS Omega 8:23, pages 21016-21025.
Crossref
Crossref
Melika Moradi, Farzaneh Vahedi, Arian Abbassioun, Arash Ramezanpour Shahi, Mohammad Sholeh, Mortaza Taheri‐Anganeh, Zahra Dargahi, Roya Ghanavati, Seyyed Hossein Khatami & Ahmad Movahedpour. (2023) Liposomal delivery system/adjuvant for tuberculosis vaccine. Immunity, Inflammation and Disease 11:6.
Crossref
Crossref
Annalaura Brai, Federica Poggialini, Claudia Pasqualini, Claudia Immacolata Trivisani, Chiara Vagaggini & Elena Dreassi. (2023) Progress towards Adjuvant Development: Focus on Antiviral Therapy. International Journal of Molecular Sciences 24:11, pages 9225.
Crossref
Crossref
Fernando Silveira, Mariana Rivera-Patron, Nikita Deshpande, Soledad Sienra, Jackeline Checa, María Moreno, Jose A. Chabalgoity, Samuel P. Cibulski & Mariana Baz. (2023) Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice. Frontiers in Immunology 14.
Crossref
Crossref
Yingying Gao & Ying Guo. (2023) Research progress in the development of natural-product-based mucosal vaccine adjuvants. Frontiers in Immunology 14.
Crossref
Crossref
Kathryn Cole, Zaid Al-Kadhimi & James E. Talmadge. (2023) Highlights into historical and current immune interventions for cancer. International Immunopharmacology 117, pages 109882.
Crossref
Crossref
Arivukarasu Palanisamy, Rinku Sharma, Prithvi Pal Singh, Upendra Sharma, Rajendra Damu Patil, Gorakh Mal & Birbal Singh. (2023) Shatavarin-IV saponin adjuvant elicits IgG and IgG2b responses against Staphylococcus aureus bacterin in a murine model. Heliyon 9:4, pages e15339.
Crossref
Crossref
Boyang Yu, Boye Li, Tian Chen, Jinning Yang, Xiaoli Wang, Bo Peng & Qin Hu. (2022) A NF-κB-Based High-Throughput Screening for Immune Adjuvants and Inhibitors. Inflammation 46:2, pages 598-611.
Crossref
Crossref
Isabel Leroux-Roels, Matthew G Davis, Katie Steenackers, Brandon Essink, Corinne Vandermeulen, Charles Fogarty, Charles P Andrews, Edward Kerwin, Marie-Pierre David, Laurence Fissette, Carline Vanden Abeele, Delphine Collete, Magali de Heusch, Bruno Salaun, Nathalie De Schrevel, Juliane Koch, Céline Verheust, Nancy Dezutter, Frank Struyf, Narcisa Mesaros, Jelena Tica & Veronica Hulstrøm. (2023) Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial. The Journal of Infectious Diseases 227:6, pages 761-772.
Crossref
Crossref
Nathaly Vasquez-Martínez, Daniel Guillen, Silvia Andrea Moreno-Mendieta, Sergio Sanchez & Romina Rodríguez-Sanoja. (2023) The Role of Mucoadhesion and Mucopenetration in the Immune Response Induced by Polymer-Based Mucosal Adjuvants. Polymers 15:7, pages 1615.
Crossref
Crossref
Kai Chen, Ning Wang, Xiaomin Zhang, Meng Wang, Yanyu Liu & Yun Shi. (2023) Potentials of saponins-based adjuvants for nasal vaccines. Frontiers in Immunology 14.
Crossref
Crossref
Shikha Shrivastava, Joshua M. Carmen, Zhongyan Lu, Shraddha Basu, Rajeshwer S. Sankhala, Wei-Hung Chen, Phuong Nguyen, William C. Chang, Jocelyn King, Courtney Corbitt, Sandra Mayer, Jessica S. Bolton, Alexander Anderson, Isabella Swafford, Guillermo D. Terriquez, Hung V. Trinh, Jiae Kim, Ousman Jobe, Dominic Paquin-Proulx, Gary, R. Matyas, Gregory D. Gromowski, Jeffrey R. Currier, Elke Bergmann-Leitner, Kayvon Modjarrad, Nelson L. Michael, M. Gordon Joyce, Allison M. W. Malloy & Mangala Rao. (2023) SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies. npj Vaccines 8:1.
Crossref
Crossref
Karolina D. Witt. (2023) Role of MHC class I pathways in Mycobacterium tuberculosis antigen presentation. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Carolin Loos, Margherita Coccia, Arnaud M. Didierlaurent, Ahmed Essaghir, Jonathan K. Fallon, Douglas Lauffenburger, Corinne Luedemann, Ashlin Michell, Robbert van der Most, Alex Lee Zhu, Galit Alter & Wivine Burny. (2023) Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design. npj Vaccines 8:1.
Crossref
Crossref
Flora Carnet, Laure Perrin-Cocon, Romain Paillot, Vincent Lotteau, Stéphane Pronost & Pierre-Olivier Vidalain. (2023) An inventory of adjuvants used for vaccination in horses: the past, the present and the future. Veterinary Research 54:1.
Crossref
Crossref
Tetsuo Nakayama, Akihito Sawada & Takeshi Ito. (2022) Comparison of cytokine production in mice inoculated with messenger RNA vaccines BNT162b2 and mRNA‐1273. Microbiology and Immunology 67:3, pages 120-128.
Crossref
Crossref
Allegra Peletta, Céline Lemoine, Thomas Courant, Nicolas Collin & Gerrit Borchard. (2023) Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines. Pharmacological Research 189, pages 106699.
Crossref
Crossref
Fuhua Wu, Ming Qin, Hairui Wang & Xun Sun. (2022) Nanovaccines to combat virus‐related diseases. WIREs Nanomedicine and Nanobiotechnology 15:2.
Crossref
Crossref
Shailendra Kumar Verma, Pooja Mahajan, Nikhlesh K. Singh, Ankit Gupta, Rupesh Aggarwal, Rino Rappuoli & Atul Kumar Johri. (2023) New-age vaccine adjuvants, their development, and future perspective. Frontiers in Immunology 14.
Crossref
Crossref
Alessio Romerio, Nicole Gotri, Ana Rita Franco, Valentina Artusa, Mohammed Monsoor Shaik, Samuel T. Pasco, Unai Atxabal, Alejandra Matamoros-Recio, Marina Mínguez-Toral, Juan Diego Zalamea, Antonio Franconetti, Nicola G. A. Abrescia, Jesus Jimenez-Barbero, Juan Anguita, Sonsoles Martín-Santamaría & Francesco Peri. (2023) New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants. Journal of Medicinal Chemistry 66:4, pages 3010-3029.
Crossref
Crossref
Cal Koger-Pease, Dilhan J. Perera & Momar Ndao. (2023) Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections. Pharmaceuticals 16:3, pages 334.
Crossref
Crossref
Etsuro Nanishi, Francesco Borriello, Hyuk-Soo Seo, Timothy R. O’Meara, Marisa E. McGrath, Yoshine Saito, Jing Chen, Joann Diray-Arce, Kijun Song, Andrew Z. Xu, Soumik Barman, Manisha Menon, Danica Dong, Timothy M. Caradonna, Jared Feldman, Blake M. Hauser, Aaron G. Schmidt, Lindsey R. Baden, Robert K. Ernst, Carly Dillen, Jingyou Yu, Aiquan Chang, Luuk Hilgers, Peter Paul Platenburg, Sirano Dhe-Paganon, Dan H. Barouch, Al Ozonoff, Ivan Zanoni, Matthew B. Frieman, David J. Dowling & Ofer Levy. (2023) Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice. npj Vaccines 8:1.
Crossref
Crossref
Ziyi Han, Junjie Jin, Xiangfeng Chen, Yanfei He & Hongxiang Sun. (2023) Adjuvant activity of tubeimosides by mediating the local immune microenvironment. Frontiers in Immunology 14.
Crossref
Crossref
Fernando Augusto Siqueira Mathias, Thais Lopes Valentim Di Paschoale Ostolin, Levi Eduardo Soares Reis, Jamille Mirelle de Oliveira Cardoso, Rory Cristiane Fortes De Brito, Rodrigo Dian de Oliveira Aguiar Soares, Bruno Mendes Roatt, Paula Melo de Abreu Vieira & Alexandre Barbosa Reis. (2023) The Use of an Adjuvant System Improves Innate and Adaptive Immune Response When Associated with a Leishmania (Viannia) braziliensis Antigen in a Vaccine Candidate against L. (Leishmania) infantum Infection. Vaccines 11:2, pages 395.
Crossref
Crossref
Feng Xu, Ye Yuan, Ying Wang & Qiliang Yin. (2023) Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection. Biomedicine & Pharmacotherapy 158, pages 114117.
Crossref
Crossref
Daniel Mieres-Castro & Freddy Mora-Poblete. (2023) Saponins: Research Progress and Their Potential Role in the Post-COVID-19 Pandemic Era. Pharmaceutics 15:2, pages 348.
Crossref
Crossref
Jinning Yang, Xiaoxiao Dong, Boye Li, Tian Chen, Boyang Yu, Xiaoli Wang, Xiangnan Dou, Bo Peng & Qin Hu. (2023) Poria cocos polysaccharide—functionalized graphene oxide nanosheet induces efficient cancer immunotherapy in mice. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Thomas J. Ellison, George C. Talbott & Daniel R. Henderson. (2023) Intradermal delivery of a quadrivalent cell-based seasonal influenza vaccine using an adjuvanted skin patch vaccination platform. Vaccine 41:2, pages 304-314.
Crossref
Crossref
Myron J. Levin. 2023. Plotkin's Vaccines. Plotkin's Vaccines
1334
1349.e7
.
Rani S. Sellers & Keith Nelson. 2023. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology
335
396
.
Bishal Misra, Krystal A. Hughes & Sharan Bobbala. 2023. Nanomedicines for the Prevention and Treatment of Infectious Diseases. Nanomedicines for the Prevention and Treatment of Infectious Diseases
297
330
.
Hemanga Hazarika, Harshita Krishnatreyya, Bedanta Bhattacharjee, Damanbhalang Rynjah, Dharmajit Gogoi, Abdul Baquee Ahmed & Kamaruz Zaman. 2023. Malarial Drug Delivery Systems. Malarial Drug Delivery Systems
161
185
.
Hyunjung Kim, Jigui Yu, Di Bai, Moon H. Nahm & Pengfei Wang. (2022) Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1. Frontiers in Immunology 13.
Crossref
Crossref
Omar Rossi & Pietro Mastroeni. (2022) Editorial: Pattern recognition receptors at the crosstalk between innate and adaptive immune systems and implications for vaccine development. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Ilaria Galgani, Margherita Annaratone, Daniela Casula, Gennaro Di Maro, Michel Janssens, Annaelisa Tasciotti, Tino Schwarz, Murdo Ferguson & Ashwani Kumar Arora. (2022) Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study. Respiratory Research 23:1.
Crossref
Crossref
Andrea Callegaro, Wivine Burny, Caroline Hervé, Joon Hyung Kim, Myron J Levin, Toufik Zahaf, Anthony L Cunningham & Arnaud M Didierlaurent. (2022) Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine. The Journal of Infectious Diseases 226:11, pages 1943-1948.
Crossref
Crossref
Ling Zhong, Claude Krummenacher, Wanlin Zhang, Junping Hong, Qisheng Feng, Qinjian Zhao, Yixin Chen, Mu-Sheng Zeng, Yi-Xin Zeng, Miao Xu & Xiao Zhang. (2022) A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus. Virology Journal 19:1.
Crossref
Crossref
Xiaochen Gong, Yuan Gao, Jianhong Shu, Chunjing Zhang & Kai Zhao. (2022) Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines. Vaccines 10:11, pages 1906.
Crossref
Crossref
Margherita Coccia, Wivine Burny, Marie-Ange Demoitié, Paul Gillard, Robert A. van den Berg & Robbert van der Most. (2022) Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses. PLOS ONE 17:11, pages e0276505.
Crossref
Crossref
Hyunjung Kim, Di Bai, Sadashib Ghosh, Michael L. Franks, Xifeng Wang, Cheng Yan, Zheng Liu, Ping Zhang, Suzanne M. Michalek, Jianmei W. Leavenworth & Pengfei Wang. (2022)
Structure–Activity Relationship Study of
Momordica
Saponin II Derivatives as Vaccine Adjuvants
. Journal of Medicinal Chemistry 65:21, pages 14589-14598.
Crossref
Crossref
Xi Yang, Yuanfeng Wei, Lingnan Zheng, Jia You, Huawei Li, Ling Gao, Changyang Gong & Cheng Yi. (2022) Polyethyleneimine-based immunoadjuvants for designing cancer vaccines. Journal of Materials Chemistry B 10:40, pages 8166-8180.
Crossref
Crossref
Thais Lopes Valentim Di Paschoale Ostolin, Miriã Rodrigues Gusmão, Fernando Augusto Siqueira Mathias, Jamille Mirelle de Oliveira Cardoso, Bruno Mendes Roatt, Rodrigo Dian de Oliveira Aguiar-Soares, Jeronimo Conceição Ruiz, Daniela de Melo Resende, Rory Cristiane Fortes de Brito & Alexandre Barbosa Reis. (2022) A specific Leishmania infantum polyepitope vaccine triggers Th1-type immune response and protects against experimental visceral leishmaniasis. Cellular Immunology 380, pages 104592.
Crossref
Crossref
Xuanxuan Nian, Jiayou Zhang, Shihe Huang, Kai Duan, Xinguo Li & Xiaoming Yang. (2022) Development of Nasal Vaccines and the Associated Challenges. Pharmaceutics 14:10, pages 1983.
Crossref
Crossref
Jake S. O’Donnell, Ariel Isaacs, Virginie Jakob, Celia Lebas, James B. Barnes, Patrick C. Reading, Paul R. Young, Daniel Watterson, Patrice M. Dubois, Nicolas Collin & Keith J. Chappell. (2022) Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine. Frontiers in Immunology 13.
Crossref
Crossref
Ashwani K. Arora, Kenneth Chinsky, Claus Keller, Irvin Mayers, Sergi Pascual-Guardia, Mercè Pérez Vera, Christophe Lambert, Stefano Lombardi, Simona Rondini, Sun Tian, Fernando Ulloa-Montoya, Luca Moraschini & Daniela Casula. (2022) A detailed analysis of possible efficacy signals of NTHi-Mcat vaccine against severe COPD exacerbations in a previously reported randomised phase 2b trial. Vaccine 40:41, pages 5924-5932.
Crossref
Crossref
Parichehr Hassanzadeh, Fatemeh Atyabi & Rassoul Dinarvand. (2022) Nanobionics: From plant empowering to the infectious disease treatment. Journal of Controlled Release 349, pages 890-901.
Crossref
Crossref
Anna Aiello, Mattia Emanuela Ligotti, Maider Garnica, Giulia Accardi, Anna Calabrò, Fanny Pojero, Hugo Arasanz, Ana Bocanegra, Ester Blanco, Luisa Chocarro, Miriam Echaide, Leticia Fernandez-Rubio, Pablo Ramos, Sergio Piñeiro-Hermida, Grazyna Kochan, Nahid Zareian, Farzin Farzaneh, David Escors, Calogero Caruso & Giuseppina Candore. (2022) How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells. International Journal of Molecular Sciences 23:17, pages 9880.
Crossref
Crossref
Adam M. Weiss, Samir Hossainy, Stuart J. Rowan, Jeffrey A. Hubbell & Aaron P. Esser-Kahn. (2022) Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems. Macromolecules 55:16, pages 6913-6937.
Crossref
Crossref
Tetsuo Nakayama, Akihito Sawada & Takeshi Ito. (2022) Increased Production of Inflammatory Cytokines after Inoculation with Recombinant Zoster Vaccine in Mice. Vaccines 10:8, pages 1339.
Crossref
Crossref
Jean-Xavier Provost-Olewczynska & Christiane Sigrid Eberhardt. (2022) Adjuvanted recombinant zoster vaccine in solid organ transplant and hematopoietic stem-cell transplant recipients. Current Opinion in Infectious Diseases 35:4, pages 312-320.
Crossref
Crossref
P. Pedrazzoli, A. Lasagna, I. Cassaniti, A. Ferrari, F. Bergami, N. Silvestris, E. Sapuppo, M. Di Maio, S. Cinieri & F. Baldanti. (2022) Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM). ESMO Open 7:4, pages 100548.
Crossref
Crossref
Jingyi Fan, Shengbin Jin, Lachlan Gilmartin, Istvan Toth, Waleed M. Hussein & Rachel J. Stephenson. (2022) Advances in Infectious Disease Vaccine Adjuvants. Vaccines 10:7, pages 1120.
Crossref
Crossref
Parkson Lee-Gau Chong, Abby Chang, Allyson Yu & Ayna Mammedova. (2022) Vesicular and Planar Membranes of Archaea Lipids: Unusual Physical Properties and Biomedical Applications. International Journal of Molecular Sciences 23:14, pages 7616.
Crossref
Crossref
Sneha Ratnapriya, Eva Perez‐Greene, Luca Schifanella & Alon Herschhorn. (2021) Adjuvant‐mediated enhancement of the immune response to HIV vaccines. The FEBS Journal 289:12, pages 3317-3334.
Crossref
Crossref
Khaled AboulFotouh, Haiyue Xu, Chaeho Moon, Robert O. WilliamsIIIIII & Zhengrong Cui. (2022) Development of (Inhalable) Dry Powder Formulations of AS01B-Containing Vaccines Using Thin-Film Freeze-Drying. International Journal of Pharmaceutics 622, pages 121825.
Crossref
Crossref
Siyoung A. Lim, Alysia Cox, Madelynn Tung & Eun Ji Chung. (2022) Clinical progress of nanomedicine-based RNA therapies. Bioactive Materials 12, pages 203-213.
Crossref
Crossref
Roberto Fuentes, Leire Aguinagalde, Carlo Pifferi, Adrián Plata, Nagore Sacristán, Donatello Castellana, Juan Anguita & Alberto Fernández-Tejada. (2022) Novel Oxime-Derivatized Synthetic Triterpene Glycosides as Potent Saponin Vaccine Adjuvants. Frontiers in Immunology 13.
Crossref
Crossref
Mehrnoush Safarzadeh, Samira Mohammadi-Yeganeh, Fatemeh Ghorbani-Bidkorbeh & Mostafa Haji Molla Hoseini. (2022) Chitosan based nanoformulation expressing miR-155 as a promising adjuvant to enhance Th1-biased immune responses. Life Sciences 297, pages 120459.
Crossref
Crossref
Stefan Andreas, Marco Testa, Laurent Boyer, Guy Brusselle, Wim Janssens, Edward Kerwin, Alberto Papi, Bonavuth Pek, Luis Puente-Maestu, Dinesh Saralaya, Henrik Watz, Tom M A Wilkinson, Daniela Casula, Gennaro Di Maro, Maria Lattanzi, Luca Moraschini, Sonia Schoonbroodt, Annaelisa Tasciotti, Ashwani K Arora, François Maltais, Guy Brusselle, Jean-Louis Corhay, Eduard Janssens, Wim Janssens, Mathias Leys, Murdo Ferguson, Mark Fitzgerald, François Maltais, Irvin Mayers, Shelly McNeil, Bonavuth Pek, Arnaud Bourdin, Laurent Boyer, Francis Couturaud, Luc Dussart, Stefan Andreas, Gabriele Illies, Andreas Eich, Andrea Ludwig-Sengpiel, Henrik Watz, Francesco Blasi, Stefano Centanni, Alberto Papi, Carlo Pomari, José Maria Echave-Sustaeta, Eleuterio Llorca Martínez, Silvia Narejos Pérez, Sergi Pascual-Guardia, Mercè Pérez Vera, Luis Puente-Maestu, Manuel Terns Riera, William Anderson, Gourab Choudhury, Anthony De-Soyza, Dinesh Saralaya, Tom MA Wilkinson, Joseph Boscia III, Kenneth Chinsky, Leonard Dunn, David Erb, Charles Fogarty, Herman Jackson Downey, Edward Kerwin, Craig Kunz, Terry Poling, Richard Sellman, Barry Sigal, John Southard, Selwyn Spangenthal, Ziad Tannous, Marco Testa, Daniela Casula, Gennaro Di Maro, Maria Lattanzi, Luca Moraschini, Sonia Schoonbroodt, Annaelisa Tasciotti & Ashwani K Arora. (2022) Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial. The Lancet Respiratory Medicine 10:5, pages 435-446.
Crossref
Crossref
Hyo Jung Nam, Sung Jun Hong, Ara Lee, Jiyeon Kim, Sangho Lee, Corey Casper, Darrick Carter, Steven G. Reed, George Simeon & Eui-Cheol Shin. (2022) An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21. npj Vaccines 7:1.
Crossref
Crossref
Francesco Serra, Irene Cassaniti, Daniele Lilleri, Paolo Pedrazzoli, Fausto Baldanti & Angioletta Lasagna. (2022) Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitors. Immunotherapy 14:6, pages 389-393.
Crossref
Crossref
Wivine Burny, Caroline Hervé, Magalie Caubet, Juan Pablo Yarzabal & Arnaud M Didierlaurent. (2022) Utility of urinary cytokine levels as predictors of the immunogenicity and reactogenicity of AS01-adjuvanted hepatitis B vaccine in healthy adults. Vaccine 40:19, pages 2714-2722.
Crossref
Crossref
Jing-Xing Yang, Jen-Chih Tseng, Guann-Yi Yu, Yunping Luo, Chi-Ying F. Huang, Yi-Ren Hong & Tsung-Hsien Chuang. (2022) Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases. Pharmaceutics 14:2, pages 423.
Crossref
Crossref
Pilar Garcia-Vello, Flaviana Di Lorenzo, Daniele Zucchetta, Alla Zamyatina, Cristina De Castro & Antonio Molinaro. (2022) Lipopolysaccharide lipid A: A promising molecule for new immunity-based therapies and antibiotics. Pharmacology & Therapeutics 230, pages 107970.
Crossref
Crossref
Gemma Moncunill, Jason Carnes, William Chad Young, Lindsay Carpp, Stephen De Rosa, Joseph J Campo, Augusto Nhabomba, Maxmillian Mpina, Chenjerai Jairoce, Greg Finak, Paige Haas, Carl Muriel, Phu Van, Héctor Sanz, Sheetij Dutta, Benjamin Mordmüller, Selidji T Agnandji, Núria Díez-Padrisa, Nana Aba Williams, John J Aponte, Clarissa Valim, Daniel E Neafsey, Claudia Daubenberger, M Juliana McElrath, Carlota Dobaño, Ken Stuart & Raphael Gottardo. (2022) Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case–control study. eLife 11.
Crossref
Crossref
NurEllene Mat Luwi, Suhana Ahmad, AhmadSuhaimi Nurfatihah Azlyna, Asyikin Nordin, MariaElena Sarmiento, Armando Acosta, MohdNor Azmi, Vuk Uskoković, Rohimah Mohamud & Ramlah Kadir. (2022) Liposomes as immunological adjuvants and delivery systems in the development of tuberculosis vaccine: A review. Asian Pacific Journal of Tropical Medicine 15:1, pages 7.
Crossref
Crossref
Zhidong Hu, Jian-Ping Chen, Jin-Chuan Xu, Zhen-Yan Chen, Rong Qu, Ling Zhang, Wenrong Yao, Juan Wu, Heng Yang, Douglas B. Lowrie, Yong Liu & Xiao-Yong Fan. (2022) A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination. Virology 566, pages 56-59.
Crossref
Crossref
Anita Milicic, Sören Reinke, Joannah Fergusson, Erik B. Lindblad, Aneesh Thakur, George Corby, Stephanie Longet, Sabina Górska, Agnieszka Razim, Kefei Hu, Bror Morein, Marina Luchner, Dennis Christensen, Slavcho Mrenoshki, Sebnem Ercelen Ceylan, Sveinbjorn Gizurarson & Malachy Chigozie Ugwu. 2022. Vaccinology and Methods in Vaccine Research. Vaccinology and Methods in Vaccine Research
223
280
.
Elizabeth G. Graham-Gurysh, Brandon W. Carpenter, Wolfgang A. Beck, Devika M. Varma, Benjamin G. Vincent, Eric M. Bachelder & Kristy M. Ainslie. 2022. Systemic Drug Delivery Strategies. Systemic Drug Delivery Strategies
359
408
.
Deep Bhattacharya, Chris Wiley, Aaron Latal & Vamsi Krishna. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development
207
224
.
Malte Meppen & Daniela Stranges. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development
137
156
.
Rushit N. Lodaya, Sonia Gregory, Mansoor M. Amiji & Derek T. O'Hagan. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development
9
25
.
Zrinka Matić & Maja Šantak. (2021) Current view on novel vaccine technologies to combat human infectious diseases. Applied Microbiology and Biotechnology 106:1, pages 25-56.
Crossref
Crossref
Paula Mendonça Leite, Juliana Mendes Amorim & Rachel Oliveira Castilho. 2022. Plants and Phytomolecules for Immunomodulation. Plants and Phytomolecules for Immunomodulation
321
360
.
Birgit Weinberger. 2022. Healthy Longevity and Immune System. Healthy Longevity and Immune System
119
164
.
Farrhana Ziana Firdaus, Mariusz Skwarczynski & Istvan Toth. 2022. Vaccine Design. Vaccine Design
145
178
.
Prashamsa Koirala, Sahra Bashiri, Istvan Toth & Mariusz Skwarczynski. 2022. Vaccine Design. Vaccine Design
309
338
.
Joshua M. Carmen, Shikha Shrivastava, Zhongyan Lu, Alexander Anderson, Elaine B. Morrison, Rajeshwer S. Sankhala, Wei-Hung Chen, William C. Chang, Jessica S. Bolton, Gary R. Matyas, Nelson L. Michael, M. Gordon Joyce, Kayvon Modjarrad, Jeffrey R. Currier, Elke Bergmann-Leitner, Allison M. W. Malloy & Mangala Rao. (2021) SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses. npj Vaccines 6:1.
Crossref
Crossref
Ana Sara Cordeiro, Yogita Patil-Sen, Maitreyi Shivkumar, Ronak Patel, Abdulwahhab Khedr & Mohamed A. Elsawy. (2021) Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application. Pharmaceutics 13:12, pages 2091.
Crossref
Crossref
Birgit Weinberger. (2021) Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond. Immunity & Ageing 18:1.
Crossref
Crossref
Philippe De Smedt, Geert Leroux-Roels, Corinne Vandermeulen, Annaelisa Tasciotti, Gennaro Di Maro, Marie Dozot, Daniela Casula, Margherita Annaratone, Daniele Riccucci & Ashwani Kumar Arora. (2021) Long-term immunogenicity and safety of a non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine: 4-year follow-up of a phase 1 multicentre trial. Vaccine: X 9, pages 100124.
Crossref
Crossref
Paola Pirrotta, Fernanda Tavares-Da-Silva, Maribel Co, Nicolas Lecrenier, Caroline Hervé & Jens-Ulrich Stegmann. (2021) An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine. Drug Safety 44:12, pages 1341-1353.
Crossref
Crossref
Sigbert Jahn, Evangelia Diamanti, Tatjana Heller, Antria Papageorgiou & Matthias Herbst. (2021) Zosterimpfung unter Biologikatherapie. ästhetische dermatologie & kosmetologie 13:6, pages 25-27.
Crossref
Crossref
Xuedan He, Shiqi Zhou, Breandan Quinn, Wei‐Chiao Huang, Dushyant Jahagirdar, Michael Vega, Joaquin Ortega, Mark D. Long, Fumito Ito, Scott I. Abrams & Jonathan F. Lovell. (2021)
Position‐Scanning Peptide Libraries as Particle Immunogens for Improving CD8
+
T‐Cell Responses
. Advanced Science 8:24.
Crossref
Crossref
Qiao Li, Zhihua Liu, Yi Liu, Chen Liang, Jiayi Shu, Xia Jin, Chuanyou Li & Zhihua Kou. (2021) A Combined Adjuvant TF–Al Consisting of TFPR1 and Aluminum Hydroxide Augments Strong Humoral and Cellular Immune Responses in Both C57BL/6 and BALB/c Mice. Vaccines 9:12, pages 1408.
Crossref
Crossref
Bassel Akache, Tyler M. Renner, Anh Tran, Lise Deschatelets, Renu Dudani, Blair A. Harrison, Diana Duque, Julie Haukenfrers, Martin A. Rossotti, Francis Gaudreault, Usha D. Hemraz, Edmond Lam, Sophie Régnier, Wangxue Chen, Christian Gervais, Matthew Stuible, Lakshmi Krishnan, Yves Durocher & Michael J. McCluskie. (2021) Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant. Scientific Reports 11:1.
Crossref
Crossref
Showkat Ahmad Dar, Sajal Kole, Su-Mi Shin, Hyeon-Jong Jeong & Sung-Ju Jung. (2021) Comparative study on antigen persistence and immunoprotective efficacy of intramuscular and intraperitoneal injections of squalene – aluminium hydroxide (Sq + Al) adjuvanted viral hemorrhagic septicaemia virus vaccine in olive flounder (Paralichthys olivaceus). Vaccine 39:47, pages 6866-6875.
Crossref
Crossref
Sakineh Pirahmadi, Shima Afzali, Mostafa Zargar, Sedigheh Zakeri & Akram Abouie Mehrizi. (2021) How can we develop an effective subunit vaccine to achieve successful malaria eradication?. Microbial Pathogenesis 160, pages 105203.
Crossref
Crossref
Eunjung Kim, Eun‐Kyung Lim, Geunseon Park, Chaewon Park, Jong‐Woo Lim, Hyo Lee, Woonsung Na, Minjoo Yeom, Jinyoung Kim, Daesub Song & Seungjoo Haam. (2021) Advanced Nanomaterials for Preparedness Against (Re‐)Emerging Viral Diseases. Advanced Materials 33:47.
Crossref
Crossref
Ana B. Enriquez, Angelo Izzo, Shannon M. Miller, Erica L. Stewart, Robert N. Mahon, Daniel J. Frank, Jay T. Evans, Jyothi Rengarajan & James A. Triccas. (2021) Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics. Frontiers in Immunology 12.
Crossref
Crossref
Brett H. Pogostin & Kevin J. McHugh. (2021) Novel Vaccine Adjuvants as Key Tools for Improving Pandemic Preparedness. Bioengineering 8:11, pages 155.
Crossref
Crossref
Srinivasa Reddy Bonam, Laurent Rénia, Ganesh Tadepalli, Jagadeesh Bayry & Halmuthur Mahabalarao Sampath Kumar. (2021) Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants. Vaccines 9:10, pages 1072.
Crossref
Crossref
So Yeon Ahn, Chau Thuy Tien Le & Eun-Ju Ko. (2021) Monophosphoryl Lipid A and Poly I:C Combination Adjuvant Promoted Ovalbumin-Specific Cell Mediated Immunity in Mice Model. Biology 10:9, pages 908.
Crossref
Crossref
Zhenchuan Wu & Keqin Liu. (2021) Overview of vaccine adjuvants. Medicine in Drug Discovery 11, pages 100103.
Crossref
Crossref
Matilde Durán-Lobato, Ana María López-Estévez, Ana Sara Cordeiro, Tamara G. Dacoba, José Crecente-Campo, Dolores Torres & María José Alonso. (2021) Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape. Advanced Drug Delivery Reviews 176, pages 113899.
Crossref
Crossref
Despo Chatzikleanthous, Derek T. O’Hagan & Roberto Adamo. (2021) Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines. Molecular Pharmaceutics 18:8, pages 2867-2888.
Crossref
Crossref
Sakineh Pirahmadi, Sedigheh Zakeri, Navid D. Djadid & Akram A. Mehrizi. (2021) A review of combination adjuvants for malaria vaccines: a promising approach for vaccine development. International Journal for Parasitology 51:9, pages 699-717.
Crossref
Crossref
Griffin J. Bell, Selidji Todagbe Agnandji, Kwaku Poku Asante, Anita Ghansah, Portia Kamthunzi, Michael Emch & Jeffrey A. Bailey. (2021) Impacts of Ecology, Parasite Antigenic Variation, and Human Genetics on RTS,S/AS01e Malaria Vaccine Efficacy. Current Epidemiology Reports 8:3, pages 79-88.
Crossref
Crossref
Patrick B. Memvanga & Christian I. Nkanga. (2021) Liposomes for malaria management: the evolution from 1980 to 2020. Malaria Journal 20:1.
Crossref
Crossref
Béatrice Laupèze, Giuseppe Del Giudice, Mark T. Doherty & Robbert Van der Most. (2021) Vaccination as a preventative measure contributing to immune fitness. npj Vaccines 6:1.
Crossref
Crossref
Hernán D. Cortés, Fernando A. Gómez & Sergio H. Marshall. (2021) The Phagosome–Lysosome Fusion Is the Target of a Purified Quillaja saponin Extract (PQSE) in Reducing Infection of Fish Macrophages by the Bacterial Pathogen Piscirickettsia salmonis. Antibiotics 10:7, pages 847.
Crossref
Crossref
Fumi Sato-KanekoShiyin YaoFitzgerald S. LaoJason NanJonathan ShpigelmanAnnette ChengTetsuya SaitoKaren MesserMinya PuNikunj M. ShuklaHoward B. CottamMichael ChanAnthony J. Molina, Maripat Corr, Tomoko Hayashi & Dennis A. Carson. (2021) Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection. Proceedings of the National Academy of Sciences 118:23.
Crossref
Crossref
Zachary R. SiaXuedan HeAli ZhangJann C. AngShuai Shao, Amal SeffouhWei-Chiao HuangMichael R. D’AgostinoAmir Teimouri Dereshgi, Sambhara Suryaprakash, Joaquin OrtegaHanne Andersen, Matthew S. Miller, Bruce A. Davidson & Jonathan F. Lovell. (2021) A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge. Proceedings of the National Academy of Sciences 118:22.
Crossref
Crossref
Bali Pulendran, Prabhu S. Arunachalam & Derek T. O’Hagan. (2021) Emerging concepts in the science of vaccine adjuvants. Nature Reviews Drug Discovery 20:6, pages 454-475.
Crossref
Crossref
Parichehr Hassanzadeh. (2021) The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing. Life Sciences 274, pages 119289.
Crossref
Crossref
Alexander K. Andrianov & Thomas R. Fuerst. (2021) Immunopotentiating and Delivery Systems for HCV Vaccines. Viruses 13:6, pages 981.
Crossref
Crossref
Katharine A. Collins, Florian Brod, Rebecca Snaith, Marta Ulaszewska, Rhea J. Longley, Ahmed M. Salman, Sarah C. Gilbert, Alexandra J. Spencer, David Franco, W. Ripley Ballou & Adrian V. S. Hill. (2021) Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice. Scientific Reports 11:1.
Crossref
Crossref
Miguel Ángel Palacios-Pedrero, Albert D. M. E. Osterhaus, Tanja Becker, Husni Elbahesh, Guus F. Rimmelzwaan & Giulietta Saletti. (2021) Aging and Options to Halt Declining Immunity to Virus Infections. Frontiers in Immunology 12.
Crossref
Crossref
Céline H. Lemoine, Reviany V. Nidom, Roland Ventura, Setyarina Indrasari, Irine Normalina, Kuncoro Puguh Santoso, Francis Derouet, Christophe Barnier-Quer, Gerrit Borchard, Nicolas Collin & Chairul A. Nidom. (2021) Better Pandemic Influenza Preparedness through Adjuvant Technology Transfer: Challenges and Lessons Learned. Vaccines 9:5, pages 461.
Crossref
Crossref
Saed Abbasi & Satoshi Uchida. (2021) Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines. Pharmaceutics 13:5, pages 644.
Crossref
Crossref
Thais Lopes Valentim Di Paschoale Ostolin, Miriã Rodrigues Gusmão, Fernando Augusto Siqueira Mathias, Jamille Mirelle de Oliveira Cardoso, Bruno Mendes Roatt, Rodrigo Dian de Oliveira Aguiar-Soares, Jeronimo Conceição Ruiz, Daniela de Melo Resende, Rory Cristiane Fortes de Brito & Alexandre Barbosa Reis. (2021) A chimeric vaccine combined with adjuvant system induces immunogenicity and protection against visceral leishmaniasis in BALB/c mice. Vaccine 39:20, pages 2755-2763.
Crossref
Crossref
Jana Zarubova, Xuexiang Zhang, Tyler Hoffman, Mohammad Mahdi Hasani-Sadrabadi & Song Li. (2021) Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases. Matter 4:5, pages 1528-1554.
Crossref
Crossref
Ki-Hye Kim, Noopur Bhatnagar, Subbiah Jeeva, Judy Oh, Bo Ryoung Park, Chong Hyun Shin, Bao-Zhong Wang & Sang-Moo Kang. (2021) Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice. Vaccines 9:4, pages 316.
Crossref
Crossref
Xuedan He, Shiqi Zhou, Wei-Chiao Huang, Amal Seffouh, Moustafa T. Mabrouk, M. Thomas Morgan, Joaquin Ortega, Scott I. Abrams & Jonathan F. Lovell. (2021)
A Potent Cancer Vaccine Adjuvant System for Particleization of Short, Synthetic CD8
+
T Cell Epitopes
. ACS Nano 15:3, pages 4357-4371.
Crossref
Crossref
Seo Ri Wui, Ara Ko, Ji In Ryu, Eojin Sim, Soo Jeong Lim, Shin Ae Park, Kwang Sung Kim, Ha Kim, Hyewon Youn & Na Gyong Lee. (2021) The Effect of a TLR4 Agonist/Cationic Liposome Adjuvant on Varicella-Zoster Virus Glycoprotein E Vaccine Efficacy: Antigen Presentation, Uptake, and Delivery to Lymph Nodes. Pharmaceutics 13:3, pages 390.
Crossref
Crossref
Susan L. Baldwin, Valerie A. Reese, Sasha E. Larsen, Elyse Beebe, Jeff Guderian, Mark T. Orr, Christopher B. Fox, Steven G. Reed & Rhea N. Coler. (2021) Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model. PLOS ONE 16:3, pages e0247990.
Crossref
Crossref
Pengfei Wang. (2021) Natural and Synthetic Saponins as Vaccine Adjuvants. Vaccines 9:3, pages 222.
Crossref
Crossref
Samuel Cibulski, Ana Paula Muterle Varela, Thais Fumaco Teixeira, Martín Pablo Cancela, Patrícia Sesterheim, Diogo Onofre Souza, Paulo Michel Roehe & Fernando Silveira. (2021) Zika Virus Envelope Domain III Recombinant Protein Delivered With Saponin-Based Nanoadjuvant From Quillaja brasiliensis Enhances Anti-Zika Immune Responses, Including Neutralizing Antibodies and Splenocyte Proliferation. Frontiers in Immunology 12.
Crossref
Crossref
Dylan J. Chand, Royford B. Magiri, Heather L. Wilson & George K. Mutwiri. (2021) Polyphosphazenes as Adjuvants for Animal Vaccines and Other Medical Applications. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Crossref
Alan H. Stokes, Kelle Franklin, Daniel E. Fisher, Lorraine M. Posobiec, Ornella Binazon, Niraj Tripathi, Michael Alan Ringenberg, Jeffrey Charlap, Mary K. Ziejewski, Vimala Vemireddi, Payal Khanna Weiss, Ritankar Majumdar, Badiaa Bouzya, Marie-Noëlle Donner, Luis-Alexander Rodriguez & Judith Baumeister. (2021) Repeated Dose Toxicity Study and Developmental and Reproductive Toxicology Studies of a Respiratory Syncytial Virus Candidate Vaccine in Rabbits and Rats. International Journal of Toxicology 40:2, pages 125-142.
Crossref
Crossref
Rodrigo Barros de Pinho, Mara Thais de Oliveira Silva, Francisco Silvestre Brilhante Bezerra & Sibele Borsuk. (2021) Vaccines for caseous lymphadenitis: up-to-date and forward-looking strategies. Applied Microbiology and Biotechnology 105:6, pages 2287-2296.
Crossref
Crossref
Xuedan He, Shiqi Zhou, Breandan Quinn, Dushyant Jahagirdar, Joaquin Ortega, Scott I. Abrams & Jonathan F. Lovell. (2021) HPV‐Associated Tumor Eradication by Vaccination with Synthetic Short Peptides and Particle‐Forming Liposomes. Small 17:11.
Crossref
Crossref
Anthony L Cunningham, Peter McIntyre, Kanta Subbarao, Robert Booy & Myron J Levin. (2021) Vaccines for older adults. BMJ, pages n188.
Crossref
Crossref
Christoph M. Janitzek, Philip H. R. Carlsen, Susan Thrane, Vijansh M. Khanna, Virginie Jakob, Christophe Barnier-Quer, Nicolas Collin, Thor G. Theander, Ali Salanti, Morten A. Nielsen & Adam F. Sander. (2021) The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration. Vaccines 9:2, pages 131.
Crossref
Crossref
Giulia Anderluzzi, Signe Tandrup Schmidt, Robert Cunliffe, Stuart Woods, Craig W. Roberts, Daniele Veggi, Ilaria Ferlenghi, Derek T. O'Hagan, Barbara C. Baudner & Yvonne Perrie. (2021) Rational design of adjuvants for subunit vaccines: The format of cationic adjuvants affects the induction of antigen-specific antibody responses. Journal of Controlled Release 330, pages 933-944.
Crossref
Crossref
Jennifer Connors, Matthew R. Bell, Jennifer Marcy, Michele Kutzler & Elias K. Haddad. (2021) The impact of immuno-aging on SARS-CoV-2 vaccine development. GeroScience 43:1, pages 31-51.
Crossref
Crossref
Cosette G. Schneider, Justin A. Taylor, Michael Q. Sibilo, Kazutoyo Miura, Katherine L. Mallory, Christopher Mann, Christopher Karch, Zoltan Beck, Gary R. Matyas, Carole A. Long, Elke Bergmann-Leitner, Peter Burkhard & Evelina Angov. (2021) Orientation of Antigen Display on Self-Assembling Protein Nanoparticles Influences Immunogenicity. Vaccines 9:2, pages 103.
Crossref
Crossref
Carlo Pifferi, Roberto Fuentes & Alberto Fernández-Tejada. (2021) Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action. Nature Reviews Chemistry 5:3, pages 197-216.
Crossref
Crossref
Zhuofan Li, Yiwen Zhao, Yibo Li & Xinyuan Chen. (2021) Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity. Vaccines 9:2, pages 75.
Crossref
Crossref
Ariel Isaacs, Zheyi Li, Stacey T. M. Cheung, Danushka K. Wijesundara, Christopher L. D. McMillan, Naphak Modhiran, Paul R. Young, Charani Ranasinghe, Daniel Watterson & Keith J. Chappell. (2021) Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines. Vaccines 9:2, pages 71.
Crossref
Crossref
Cedric Bosteels, Kaat Fierens, Sofie De Prijck, Justine Van Moorleghem, Manon Vanheerswynghels, Caroline De Wolf, Aurélie Chalon, Catherine Collignon, Hamida Hammad, Arnaud M. Didierlaurent & Bart N. Lambrecht. (2021) CCR2- and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01. Frontiers in Immunology 11.
Crossref
Crossref
Xiaoxiao Dong, Boye Li, Boyang Yu, Tian Chen, Qin Hu, Bo Peng & Wang Sheng. (2021) Poria cocos polysaccharide induced Th1-type immune responses to ovalbumin in mice. PLOS ONE 16:1, pages e0245207.
Crossref
Crossref
Ana Rita Franco & Francesco Peri. (2021) Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants. Cells 10:1, pages 78.
Crossref
Crossref
Shuyang Guo, Wenbo Sai & Min Li. (2021) Malaria vaccine development. One Health Bulletin 1:1, pages 12-16.
Crossref
Crossref
Shinichi IMAFUKU. (2021) Herpes zoster and subunit vaccine帯状疱疹の発症機構の考察と成分ワクチンについて. Uirusu 71:1, pages 45-54.
Crossref
Crossref
Maria Edilene Martins de Almeida, Maria Gabriella Santos de Vasconcelos, Andréa Monteiro Tarragô & Luís André Morais Mariúba. (2021) Circumsporozoite Surface Protein-based malaria vaccines: a review. Revista do Instituto de Medicina Tropical de São Paulo 63.
Crossref
Crossref
Yuchen Fan, Maria Marioli & Kelly Zhang. (2021) Analytical characterization of liposomes and other lipid nanoparticles for drug delivery. Journal of Pharmaceutical and Biomedical Analysis 192, pages 113642.
Crossref
Crossref
Yizhi Qi & Christopher B. Fox. (2021) A Two-Step Orthogonal Chromatographic Process for Purifying the Molecular Adjuvant QS-21 with High Purity and Yield. Journal of Chromatography A 1635, pages 461705.
Crossref
Crossref
Calogero Caruso, Anna Aiello, Graham Pawelec & Mattia Emanuela Ligotti. 2021. Human Aging. Human Aging
129
153
.
Shakila Harshavardhan, Kevin Kumar Vijayakumar & Vignesh Sounderrajan. 2021. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy
213
227
.
Nathalie Garçon. 2021. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations
41
48
.
Mangala Rao, Kristina K. Peachman & Carl R. Alving. 2021. Nanoparticles for Rational Vaccine Design. Nanoparticles for Rational Vaccine Design
1
28
.
Đani Škalamera, Hyunjung Kim, Ping Zhang, Suzanne M. Michalek & Pengfei Wang. (2020) Impact of C28 Oligosaccharide on Adjuvant Activity of QS-7 Analogues. The Journal of Organic Chemistry 85:24, pages 15837-15848.
Crossref
Crossref
N. A. Alpatova, Zh. I. Avdeeva, S. L. Lysikova, O. V. Golovinskaya & L. A. Gayderova. (2020) General Characteristics of Adjuvants and Their Mechanism of Action (Part 1). BIOpreparations. Prevention, Diagnosis, Treatment 20:4, pages 245-256.
Crossref
Crossref
Parichehr Hassanzadeh. (2020) Nanotheranostics against COVID-19: From multivalent to immune-targeted materials. Journal of Controlled Release 328, pages 112-126.
Crossref
Crossref
Matthew D. Heath, Mona O. Mohsen, Pieter-Jan de Kam, Thalia L. Carreno Velazquez, Simon J. Hewings, Matthias F. Kramer, Thomas M. Kündig, Martin F. Bachmann & Murray A. Skinner. (2020) Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®). Frontiers in Immunology 11.
Crossref
Crossref
Ozlem Bulut, Gizem Kilic, Jorge Domínguez-Andrés & Mihai G Netea. (2020) Overcoming immune dysfunction in the elderly: trained immunity as a novel approach. International Immunology 32:12, pages 741-753.
Crossref
Crossref
Dumar A. Jaramillo-Hernández, Luis F. Salazar-Garcés, Mónica M. Baquero-Parra, Carina Da Silva-Pinheiro & Neuza M. Alcantara-Neves. (2020) Toxocariasis y vacunación para Toxocara: una revisión sistemática. Orinoquia 24:2, pages 79-95.
Crossref
Crossref
Laurane De Mot, Viviane Bechtold, Vanesa BolAndrea CallegaroMargherita Coccia, Ahmed Essaghir, Dicle HasdemirFernando Ulloa-MontoyaEmilio Siena, Age SmildeRobert A. van den Berg, Arnaud M. Didierlaurent, Wivine BurnyRobbert G. van der Most. (2020) Transcriptional profiles of adjuvanted hepatitis B vaccines display variable interindividual homogeneity but a shared core signature. Science Translational Medicine 12:569.
Crossref
Crossref
Sundas Nasir Chaudhry, Abu Hazafa, Muhummad Mumtaz, Ume Kalsoom, Saima Abbas, Amna Kainaat, Shahid Bilal, Nauman Zafar, Aleena Siddique & Ayesha Zafar. (2020) New insights on possible vaccine development against SARS-CoV-2. Life Sciences 260, pages 118421.
Crossref
Crossref
Displaying 200 of 316 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list